Adial Pharmaceuticals Plans to Name Celia Economides CFO

• Adial Pharmaceuticals expects to appoint Executive Vice President of Finance Celia Economides as chief financial officer, succeeding Vinay Shah.
• The appointment is expected promptly following the reconvened 2026 annual stockholder meeting, subject to approval of certain proposals.
• Chief Development Officer Matt Davidson is expected to become president and chief executive officer at the same time.
• Economides joined in August 2026, having previously served as chief financial officer and chief business officer at CellCentric.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610260800PRIMZONEFULLFEED9852921) on October 26, 2026, and is solely responsible for the information contained therein.